ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy

BACKGROUND: Patients with hepatocellular carcinoma (HCC) may develop end-stage renal disease and receive dialysis, but the impact of dialysis on the prognosis is unclear. This study aimed to evaluate the outcome of dialysis HCC patients and the prognostic role of albumin-bilirubin (ALBI) grade in th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Autores principales: Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Ko, Chih-Chieh, Huang, Yi-Hsiang, Su, Chien-Wei, Hsia, Cheng-Yuan, Lee, Rheun-Chuan, Hou, Ming-Chih, Huo, Teh-Ia
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107592/
https://ncbi.nlm.nih.gov/pubmed/34012661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-332
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares